{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:24:28Z","timestamp":1794579868387,"version":"4.9.1"},"reference-count":61,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10,29]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>TFL is most commonly of the germinal center B-cell-like phenotype, but a significant minority of cases is of the ABC phenotype (16%). The absence of BCL2 translocation in FL at diagnosis is associated with transformation into ABC-like large cell lymphoma.<\/jats:p>","DOI":"10.1182\/blood-2015-06-649905","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T22:24:36Z","timestamp":1440541476000},"page":"2118-2127","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":120,"title":["Cell of origin of transformed follicular lymphoma"],"prefix":"10.1182","volume":"126","author":[{"given":"Robert","family":"Kridel","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mottok","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Farinha","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ben-Neriah","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Zheng","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chavez","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennady P.","family":"Shulha","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King","family":"Tan","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Chun","family":"Chan","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill","family":"Boyle","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Meissner","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Telenius","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie H.","family":"Sehn","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[{"name":"Canada\u2019s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab P.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, and"},{"name":"Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111906390363000_B1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project.","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"issue":"3","key":"2019111906390363000_B2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/leu.2014.251","article-title":"Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study.","volume":"29","author":"Junl\u00e9n","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"2019111906390363000_B3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2012.082412","article-title":"Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.","volume":"98","author":"Bachy","year":"2013","journal-title":"Haematologica"},{"issue":"32","key":"2019111906390363000_B4","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma.","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol"},{"issue":"26","key":"2019111906390363000_B5","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.","volume":"31","author":"Link","year":"2013","journal-title":"J Clin Oncol"},{"issue":"17","key":"2019111906390363000_B6","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111906390363000_B7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.","volume":"15","author":"Bastion","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111906390363000_B8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","article-title":"Transformation of follicular lymphoma.","volume":"24","author":"Lossos","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"2019111906390363000_B9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00277-015-2303-5","article-title":"Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.","volume":"94","author":"Lerch","year":"2015","journal-title":"Ann Hematol"},{"issue":"10","key":"2019111906390363000_B10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdl162","article-title":"The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.","volume":"17","author":"Gin\u00e9","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"2019111906390363000_B11","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma.","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood"},{"issue":"8","key":"2019111906390363000_B12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/1042819031000090228","article-title":"Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma.","volume":"44","author":"Do","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2019111906390363000_B13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation.","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Reports"},{"issue":"1","key":"2019111906390363000_B14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","article-title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.","volume":"113","author":"Cheung","year":"2009","journal-title":"Blood"},{"issue":"15","key":"2019111906390363000_B15","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2008-08-174839","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.","volume":"113","author":"Carlotti","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111906390363000_B16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"10","key":"2019111906390363000_B17","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood-2008-08-174953","article-title":"Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.","volume":"113","author":"O\u2019Shea","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111906390363000_B18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas.","volume":"80","author":"Yano","year":"1992","journal-title":"Blood"},{"issue":"13","key":"2019111906390363000_B19","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111906390363000_B20","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma.","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood"},{"issue":"7","key":"2019111906390363000_B21","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas.","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"issue":"7","key":"2019111906390363000_B22","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.leu.2404696","article-title":"Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma.","volume":"21","author":"Fitzgibbon","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"2019111906390363000_B23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.","volume":"136","author":"Davies","year":"2007","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111906390363000_B24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2403802","article-title":"A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.","volume":"19","author":"Davies","year":"2005","journal-title":"Leukemia"},{"issue":"17","key":"2019111906390363000_B25","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111906390363000_B26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2019111906390363000_B27","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111906390363000_B28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis.","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"issue":"20","key":"2019111906390363000_B29","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"issue":"24","key":"2019111906390363000_B30","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111906390363000_B31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.2014.55.5714","article-title":"Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.","volume":"33","author":"Nowakowski","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111906390363000_B32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"2019111906390363000_B33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111906390363000_B34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"issue":"14","key":"2019111906390363000_B35","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"17","key":"2019111906390363000_B36","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","article-title":"VarScan: variant detection in massively parallel sequencing of individual and pooled samples.","volume":"25","author":"Koboldt","year":"2009","journal-title":"Bioinformatics"},{"issue":"3","key":"2019111906390363000_B37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"9","key":"2019111906390363000_B38","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111906390363000_B39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10985-008-9095-z","article-title":"Weighted analyses for cohort sampling designs [published correction appears in Lifetime Data Anal. 2009;15(3):411].","volume":"15","author":"Gray","year":"2009","journal-title":"Lifetime Data Anal"},{"key":"2019111906390363000_B40","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies [published online ahead of print August 3, 2015].","author":"Scott","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111906390363000_B41","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"25","key":"2019111906390363000_B42","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"5870","key":"2019111906390363000_B43","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"7277","key":"2019111906390363000_B44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"7332","key":"2019111906390363000_B45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma.","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"2","key":"2019111906390363000_B46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.22126","article-title":"Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.","volume":"53","author":"Bohers","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"2019111906390363000_B47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111906390363000_B48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.immuni.2013.04.009","article-title":"Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.","volume":"38","author":"Ochiai","year":"2013","journal-title":"Immunity"},{"issue":"7","key":"2019111906390363000_B49","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.1303216","article-title":"Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism.","volume":"192","author":"Willis","year":"2014","journal-title":"J Immunol"},{"issue":"7","key":"2019111906390363000_B50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/modpathol.3880373","article-title":"Analysis of MUM1\/IRF4 protein expression using tissue microarrays and immunohistochemistry.","volume":"14","author":"Natkunam","year":"2001","journal-title":"Mod Pathol"},{"issue":"6","key":"2019111906390363000_B51","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdp460","article-title":"Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.","volume":"21","author":"Sweetenham","year":"2010","journal-title":"Ann Oncol"},{"issue":"10","key":"2019111906390363000_B52","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.humpath.2014.06.019","article-title":"Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.","volume":"45","author":"Xerri","year":"2014","journal-title":"Hum Pathol"},{"issue":"6","key":"2019111906390363000_B53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111906390363000_B54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/annonc\/mdu537","article-title":"Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.","volume":"26","author":"Madsen","year":"2015","journal-title":"Ann Oncol"},{"issue":"9880","key":"2019111906390363000_B55","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(13)60313-X","article-title":"Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.","volume":"381","author":"Cunningham","year":"2013","journal-title":"Lancet"},{"issue":"6769","key":"2019111906390363000_B56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"5","key":"2019111906390363000_B57","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2019111906390363000_B58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.2014.57.7080","article-title":"Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis.","volume":"33","author":"Dybk\u00e6r","year":"2015","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019111906390363000_B59","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111906390363000_B60","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111906390363000_B61","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/18\/2118\/1389627\/2118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/18\/2118\/1389627\/2118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T06:39:29Z","timestamp":1574145569000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/18\/2118\/34503\/Cell-of-origin-of-transformed-follicular-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":61,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,10,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-06-649905","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]}}}